A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System(DSS)
| Registry | NCT01461005, acronym DSS |
|---|---|
| Status | Terminated - FDA reclassified so all 522 studies were stopped, |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, treatment |
| Enrollment | 1 (Actual) |
| Sponsor | Paradigm Spine (Industry); collaborators: MCRA |
| Conditions | Spondylolisthesis, Neurologic Deficits, Kyphosis, Pseudarthrosis |
| Interventions | Dynamic Stabilization System (DSS) (Device) |
| Dates | start 2011-09-01, primary completion 2016-09-01, completion 2016-09-01, first posted 2011-10-27, last updated 2020-02-19 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
All trials for Spondylolisthesis All trials for Neurologic Deficits All trials of Dynamic Stabilization System (DSS)
The purpose of the Post-Market Surveillance study is to evaluate safety.
Paradigm Spine Dynamic Stabilization System (DSS) study is a prospective, multi-center, literature controlled study.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Dynamic Stabilization System | Experimental | Device: Dynamic Stabilization System (DSS) | Dynamic Stabilization System (DSS) System |
Sex: All, ages: 21 Years to 85 Years
Inclusion Criteria: * Patient is skeletally mature (21-85 years old). * Patient has degenerative spondylolisthesis (Grade 1-3) with objective evidence of neurologic impairment, kyphosis, and/or failed previous fusion (pseudarthrosis) at index level. * Capable and willing to comply with the requirements unique to the study, adhere to the post-operative treatment and management program, and return for required follow-up examinations. * Surgeon has determined that DSS™ System is an appropriate treatment for the patient without regard to the study. Exclusion Criteria: * The need for interbody cages, allograft, or any other assistance during surgery. Device is only to be used with autograft per FDA approved indications. * Any medical, mental or surgical condition precluding the potential benefit of spinal surgery or surgery in general. * Acute or chronic systemic, spinal or localized infections. * Active, severe systemic and metabolic diseases. * Obesity defined as Body Mass Index > 35. * Subject is pregnant or interested in becoming pregnant in the next 36 months. * Dependency on pharmaceutical drugs, drug abuse, or alcoholism. * Lack of patient cooperation. * Foreign body sensitivity to the implant material. * Degenerative scoliosis greater than 25 degrees. * Grade 4 degenerative spondylolisthesis (>75% slip). * Significant osteopenia A screening questionnaire for osteopenia, SCORE (Simple Calculated Osteoporosis Risk Estimation), will be used to screen patients who require a DEXA bone mineral density measurement. If DEXA is required*, exclusion will be defined as a DEXA bone density measured T score of ≤ -1.0 (The World Health Organization definition of osteopenia). * Soft tissue deficit not allowing wound closure. * Congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of the device. * Inadequate pedicles or vertebral body geometry of the thoracic, lumbar and sacral vertebrae. * Bony lumbar spinal stenosis not related to the primary degenerative spondylolisthesis indication. * Pars defect. * Clinically compromised vertebral bodies at affected level due to current or past trauma. * Prisoner or ward of the state. * Currently in litigation regarding a spinal condition. * Known allergy to titanium, titanium alloys, CoCrMo, polyethylene or MR contrast agents. * Is currently involved in a study of another investigational product for similar purpose.
| Milestone | Dynamic Stabilization System |
|---|---|
| Started | 1 |
| Completed | 0 |
| Not completed | 1 |
Time frame: 6 months
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|---|---|---|
| Dynamic Stabilization System | 0 | 0/1 (0.0%) | 0/1 (0.0%) |
| Facility | City | Country | Status |
|---|---|---|---|
| University of California, Davis Medical Center | Sacramento, California | United States |